logo

Flex Pharma Inc. (FLKS)



Trade FLKS now with
  Date
  Headline
6/25/2019 7:08:12 AM Flex Pharma Announces Broker Authority To Vote On Certain Proposals
3/6/2019 7:21:08 AM Flex Pharma Reports Q4 Net Loss $2.0 Mln Or $0.11 Per Share
1/4/2019 7:03:00 AM Flex Pharma And Salarius To Merge
12/6/2018 3:32:51 AM Asceneuron Appoints Thomas Wessel As Chief Medical Officer
11/5/2018 7:14:16 AM Flex Pharma Q3 Net Loss $2.6 Mln Or $0.15/Shr Vs Loss $9.33 Mln Or $0.54/Shr Last Year
8/1/2018 7:18:45 AM Flex Pharma Q2 Loss/shr $0.50 Vs. Loss/shr $0.51 Last Year
6/13/2018 7:11:22 AM Flex Pharma Trading Expected To Resume At 7:30 PM ET
6/13/2018 7:05:09 AM Flex Pharma Plans Reducing Its Workforce By Approximately 60%
6/13/2018 7:03:15 AM Flex Pharma Trading Halted Pending News
5/2/2018 7:17:49 AM Flex Pharma Posts Q1 Net Loss $8.2 Mln Or $0.46/Shr Vs Loss $8.27 Mln Or $0.49/Shr Last Year
4/6/2018 8:51:33 AM Jefferies Is Cutting Flex Pharma Inc. (FLKS) 2020 Estimate To -1.53 From -1.30
4/6/2018 8:51:15 AM Jefferies Is Lowering Flex Pharma Inc. (FLKS) 2019 Estimate To -1.96 From -1.50
4/6/2018 8:50:54 AM Jefferies Is Cutting Flex Pharma Inc. (FLKS) 2018 Estimate To -2.01 From -1.88
3/26/2018 7:05:20 AM Flex Pharma Reports Positive Topline Data From Exploratory Phase 2 Trial Of FLX-787 In Multiple Sclerosis
3/7/2018 7:07:31 AM Flex Pharma Posts Q4 Net Loss Of $8.0 Mln Or $0.46/Shr